ELISA Kit for Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)

Specificity

This assay has high sensitivity and excellent specificity for detection of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1).
No significant cross-reactivity or interference between Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) and the recovery rates were calculated by comparing the measured value to the expected amount of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 89-96 92
EDTA plasma(n=5) 80-96 86
heparin plasma(n=5) 81-93 88

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 92-99% 85-101% 80-105% 98-105%
EDTA plasma(n=5) 80-104% 92-101% 89-98% 88-96%
heparin plasma(n=5) 93-102% 95-104% 82-90% 84-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clin Exp Nephrol Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome PubMed: 26351173
Journal of Proteome Research Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study pubmed:28112944
OncoTargets and Therapy leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter Pubmed:29785123
PROTEOMICS – Clinical Applications Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset … Pubmed: 30411527
Cancer Management and Research iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia Pubmed: 31440093
J Clin Med A Three-Protein Panel to Support the Diagnosis of Sepsis in Children Pubmed:35329889
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB934Ra01 Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB934Ra02 Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB934Ra01 Polyclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) WB; IHC; ICC; IP.
PAB934Ra02 Polyclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) WB; IHC; ICC; IP.
MAB934Ra22 Monoclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) WB; IHC; ICC; IP.
MAB934Ra21 Monoclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) WB; IHC; ICC; IP.
SEB934Ra ELISA Kit for Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB934Ra Multiplex Assay Kit for Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.